Humacyte, Inc. (HUMA)
NASDAQ: HUMA · IEX Real-Time Price · USD
3.110
+0.010 (0.32%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Humacyte Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Humacyte stock have an average target of 7.00, with a low estimate of 3.00 and a high estimate of 15. The average target predicts an increase of 125.08% from the current stock price of 3.11.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 1 | 1 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 3 | 4 | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Hold Maintains $4 | Hold | Maintains | $4 | +28.62% | Mar 26, 2024 |
Benchmark | Benchmark | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +382.32% | Mar 25, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +28.62% | Mar 8, 2024 |
Benchmark | Benchmark | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +382.32% | Dec 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +92.93% | Dec 11, 2023 |
Financial Forecast
Revenue This Year
58.28K
from 1.57M
Decreased by -96.28%
Revenue Next Year
3.65M
from 58.28K
Increased by 6,162.57%
EPS This Year
-1.08
from -0.12
EPS Next Year
-0.97
from -1.08
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | 315,000 | 7.4M | 44.6M | 155.0M | 311.1M | 531.4M |
Avg | 58,283 | 3.7M | 34.4M | 108.6M | 224.7M | 373.0M |
Low | n/a | 686,000 | 26.1M | 64.1M | 141.3M | 220.8M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | -79.9% | 12,510.9% | 1,122.6% | 350.9% | 186.4% | 136.5% |
Avg | -96.3% | 6,162.6% | 841.8% | 216.0% | 106.8% | 66.0% |
Low | - | 1,077.0% | 614.2% | 86.5% | 30.1% | -1.7% |
EPS Forecast
EPS | 2023 | 2024 | 2025 |
---|---|---|---|
High | -0.97 | -0.90 | -0.65 |
Avg | -1.08 | -0.97 | -0.82 |
Low | -1.08 | -1.01 | -1.01 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.